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Background: Single-walled carbon nanotubes (SWCNT) hold promise for applications as 
contrast agents and target delivery carriers in the field of nanomedicine. When administered 
in vivo, their biodistribution and pharmacological profile needs to be fully characterized. 
The tissue distribution of carbon nanotubes and their potential impact on metabolism depend 
on their shape, coating, and metallic impurities. Because standard radiolabeled or fluorescently-
labeled pharmaceuticals are not well suited for long-term in vivo follow-up of carbon nanotubes, 
alternative methods are required.
Methods: In this study, noninvasive in vivo magnetic resonance imaging (MRI) investigations 
combined with high-resolution magic angle spinning (HR-MAS), Raman spectroscopy, iron 
assays, and histological analysis ex vivo were proposed and applied to assess the biodistribution 
and biological impact of intravenously injected pristine (raw and purified) and functionalized 
SWCNT in a 2-week longitudinal study. Iron impurities allowed raw detection of SWCNT in 
vivo by susceptibility-weighted MRI.
Results: A transitional accumulation in the spleen and liver was observed by MRI. Raman 
spectroscopy, iron assays, and histological findings confirmed the MRI readouts. Moreover, 
no acute toxicological effect on the liver metabolic profile was observed using the HR-MAS 
technique, as confirmed by quantitative real-time polymerase chain reaction analysis.
Conclusion: This study illustrates the potential of noninvasive MRI protocols for longitudinal 
assessment of the biodistribution of SWCNT with associated intrinsic metal impurities. The 
same approach can be used for any other magnetically-labeled nanoparticles.
Keywords: single-walled carbon nanotubes, magnetic resonance imaging, high resolution 
magic angle spinning
Introduction
Single-walled carbon nanotubes (SWCNT), with their unique nanometer-scale structure 
based on a single layer of carbon atoms arranged in a series of condensed benzene 
rings rolled up into a tubular structure, and their fascinating mechanical, electric, 
and thermal properties, are being used more and more extensively for a variety of 
applications in nanotechnology.1 With their distinct architecture which allows them 
to penetrate selectively across biological barriers and their novel physicochemical 
properties, in particular, their high aspect ratio and propensity for functional modifica-
tion, SWCNT hold promise for applications in the field of nanomedicine as contrast 
agents and target delivery carriers to improve the distribution and performance of drug 
molecules.2,3 For example, SWCNT have been shown to shuttle various biomolecules 
into cells effectively, including drugs, peptides, proteins, plasmid DNA, and small 
interfering RNA.4International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The biodistribution and pharmacological profile of 
carbon nanotubes in vivo have yet to be fully characterized 
for safe biomedical application. Chemical modifications or 
functionalization of their surfaces render carbon nanotubes 
more hydrophilic, which can improve their biocompatibility 
profile and reduce aggregation of individual tubes through 
van der Waals forces.5,6 In addition, in vitro studies of well-
dispersed SWCNT have reported less cytotoxicity when 
compared with the same SWCNT present in an agglomerated 
form.7,8 Finally, the tissue distribution of carbon nanotubes 
and their potential impact on metabolism depends on their 
shape, coating, and metallic impurities.9
Rather than relying on radiolabels or spectroscopic 
tags for indirect detection of carbon nanotubes, which may 
gradually dissociate from the materials they are attached 
to, decay, and lose activity over time, direct detection of 
carbon nanotubes can be performed based on their intrinsic 
physical properties, ie, intrinsic Raman scattering intensity10 
and intrinsic near infrared photoluminescence,11,12 which 
allow for their specific and direct detection. However, these 
techniques are more adapted to ex vivo or in vivo surface 
investigations due to poor penetration of these detection 
methods inside the body.
In a previous study, we proposed an in vivo follow-up 
method to detect SWCNT noninvasively, based on their metal 
impurity at the surface or inside raw SWCNT (depending on 
the manufacturer and synthesis methods) using susceptibility-
weighted magnetic resonance imaging (MRI).13 MRI has 
potential advantages over other noninvasive modalities with 
respect to high soft-tissue resolution deep inside the body and 
discrimination in any imaging plane, and the lack of repeated 
exposure to ionizing radiation during longitudinal studies.
Among techniques to evaluate biological impact, nuclear 
magnetic resonance (NMR) spectroscopy is unique in its 
ability to obtain pertinent metabolic information about the 
target organs and biomarker metabolites.14 However, in vivo 
NMR spectroscopy is often limited by its poor spectral reso-
lution and sensitivity, resulting in ambiguity in metabolite 
assignment and quantification. High-resolution magic angle 
spinning (HR-MAS) enables setting up of richer metabolite 
profiles for ex vivo tissues (biopsies) by providing much 
higher spectral resolution and sensitivity.
MAS NMR spectroscopy is a nondestructive technique 
requiring small amounts and minimal sample preparation. 
This technique has been successfully applied to the analysis 
of biological samples, including the brain, liver, kidney, 
intestine, cardiac tissue, and prostate. Pattern recogni-
tion methods (ie, multivariate statistical methods) enable 
  convenient   visualization of spectral changes in NMR data, 
and are useful for the detection of specific biomarkers of 
toxicity and for diagnosis of disease.15–17
Quantitative real-time polymerase chain reaction 
  (RT-PCR) was performed to confirm results obtained by 
MAS NMR spectroscopy. We used this powerful tool to iden-
tify and characterize changes in gene expression   associated 
with toxicity.
In a previous study, after intrapulmonary instillation in a 
rat model, raw SWCNT were found to produce   granulomatous 
and inflammatory reactions in a time- and dose-dependent 
manner assessed by multiscale imaging techniques combin-
ing noninvasive hyperpolarized 3He and proton lung MRI 
with ex vivo light (histopathological analysis) and transmis-
sion electron microscopy.18
In this two-week follow-up study, we investigated the 
biodistribution of various SWCNT in blood and target tissues 
after their intravenous administration by longitudinal in vivo 
systemic MRI and their potential effect on liver metabolism 
by HR-MAS spectroscopy and quantitative RT-PCR analysis 
after liver biopsy. Ex vivo Raman spectroscopy, iron assay, 
and histological analysis were performed to correlate with 
the MRI readouts.
Materials and methods
Nanoparticle suspension
Three different types of SWCNT were used in this study. Raw 
and purified pristine SWCNT were purchased from Carbon 
Nanotechnologies Inc (Buckytubes, Houston, TX). They have 
an individual diameter of 0.8 to 1.2 nm and an individual 
length of 0.1 to 1 µm, according to the   manufacturer. Pris-
tine SWCNT were well-dispersed in NaCl in the presence of 
bovine serum albumin after at least 20 minutes sonication in 
an ultrasonic bath.19 Functionalized SWCNT were purchased 
from Sigma-Aldrich (Lyon, France). They have an individual 
diameter of 1 to 2 nm and an individual length of 0.5 to 2 µm. 
The functionalization was achieved by suspending 60 mg of 
SWCNT in 20 mL of concentrated HNO3 (15 M) and 60 mL 
of concentrated H2SO4 (18 M). The mixture was stirred at 
70°C for 2 hours. It was then filtered, washed with distilled 
water until the pH of the aqueous phase was neutral, and 
dried at 120°C for 12 hours. The oxidized materials were 
redispersed in water at a concentration of 3 mg/mL. This 
protocol was adapted from Liu et al.20
An ultrasmall supermagnetic iron oxide (USPIO) con-
trast agent, Sinerem® (Ferumoxtran-10) kindly provided by 
Guerbet (Paris, France), was also included in this study as 
a positive control for contrast MRI. It has a mean particle International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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diameter of 30 nm and consists of an iron oxide core coated 
with low molecular weight dextran.21
Physicochemical characteristics
SWCNT have been previously characterized using transmis-
sion electron microscopy.13 Prior to administration in vivo, 
their physicochemical properties were carefully characterized 
by Raman spectroscopy, superconducting quantum inter-
ference device (SQUID) magnetization measurement, and 
inductively coupled plasma-optical emission spectrometry 
(ICP-OES) for iron impurity.
raman spectroscopy
Raman spectroscopy is a technique used to study vibra-
tional, rotational, and other low-frequency modes in a 
system. It tells us about the quality of the nanotubes and 
their microscopic structure. Volumes as low as 10 µL of 
each sample were used to obtain the Raman signatures 
(RBM and G-band) of SWCNT using a labRAM ARAMIS 
microspectrometer Raman instrument (HORIBA Jobin 
Yvon Inc, Edison, NJ). The Raman spectrum was recorded 
using a laser spot of 2 µm2 (6 mW power on the sample, 
laser excitation wavelength 632.5 nm), 50× objective, and 
a 10-second collection time.
sQUID measurements
SQUID is a very sensitive magnetometer used to measure 
extremely weak magnetic fields. The magnetic properties 
of the samples were characterized with a Quantum Design 
MPMS-XL magnetometer based on a SQUID. For the 
  zero-field-cooled measurements, the sample is first cooled 
from 300 to 5 K in a zero magnetic field. After applying a 
50 Oe magnetic field, the magnetization is measured in a 
warming cycle. For the field-cooled measurements, SWCNT 
samples were cooled in the magnetic field from room tem-
perature to 5 K, and then the magnetization was measured in 
the warming cycle while keeping the field on. Samples were 
encapsulated in diamagnetic cellulose for measurements and 
run in duplicate.
Iron dosage
Iron metal impurities were measured in the different SWCNT 
solutions prior to their in vivo administration, and 1 mL 
of each solution was analyzed. Samples were centrifuged 
(30 minutes, 10,000 rpm) and then mineralized at 200°C for 
45 minutes with 7 mL of nitric acid in a microwave oven 
(MarsXpress, Matthews, NC). Digested samples were diluted 
to 250 mL with ultrapure water (18 MΩ) and analyzed by 
ICP-OES using a JY138 Ultrace instrument (HORIBA Jobin 
Yvon Inc) transformed into an axial view prototype, operat-
ing at 1075 W and equipped with a Meinhard-type nebulizer 
and a Scott spray chamber. Detection was performed at 
259.94 nm.
experimental protocol
Six- to eight-week-old male Sprague-Dawley rats (n = 40) 
were obtained from Charles River (L’Arbresle, France). 
The animals were housed in the Lyon-1 University   animal 
care unit, a facility accredited by the local veterinary 
  authority. They had free access to a conventional labora-
tory diet and water, and were handled in accordance with 
official French guidelines for the care and use of laboratory 
animals. The animals were anesthetized by intramuscular 
administration of 0.12 mL/100 g of a mixture of 3.5 mL of 
ketamine (1000 mg/mL), 3 mL of xylazine (2%), and 1 mL 
of atropine (1 mg/mL).
They were divided in five groups of eight rats each, ie, two 
control groups injected with either saline   (negative control) 
or USPIO (positive control), and three groups injected with 
raw, purified, or functionalized SWCNT. Nanoparticle solu-
tions (the different SWCNT and USPIO) were intravenously 
injected as a single bolus via the vein tail (0.5 mg/animal in a 
150 µL volume) and the MRI protocol was performed 1 hour 
before injection and at 5 hours, 24 hours (day 1), 48 hours 
(day 2), 7 days (day 7), and 14 days (day 14) after injection 
of nanoparticles.
MrI protocol
MRI was performed on a 10 cm bore actively-shielded 
4.7 T Bruker magnet (Bruker Biospin GmbH, Rheinstetten, 
  Germany) interfaced to ParaVision software for   preclinical 
MRI research. A Bruker transmission and reception proton 
volume radiofrequency coil was used for good radiofrequency 
homogeneity over the volume of interest. A gradient echo 
sequence with TR/TE = 200/3.6 msec, bandwidth = 50 kHz, 
flip angle = 30°, FOV = 6 cm, two averages, and a pixel resolu-
tion of 234 × 234 µm was used. Axial slices   (thickness 2 mm) 
were positioned so as to image the organs of interest (liver, 
spleen, and kidneys). A water tube used as a reference was 
positioned on the rat to enable contrast-to-noise ratio (CNR) 
measurement and proton NMR signal normalization.
The contrast-to-noise ratio was defined as (SNRROI - SNRref  )/
SNRref with SNR = (MeanSignal /SDNoise) where ref denotes the 
water tube reference and SD is the standard deviation of the 
noise in the image. Within the liver, the regions of interest were 
drawn around apparent vascular structures and these regions International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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were subtracted out of the map to retain liver   parenchyma only. 
Regions of interest   encompassing the whole spleen and the two 
kidneys were manually selected for signal   measurement. All 
data were expressed as means ± SD. Nonparametric statistical 
tests (SPSS; SPSS Inc., Chicago, IL) were done, ie, Kruskal–
Wallis for unpaired groups and a Friedman test for comparison 
between different time points. A P value , 0.05 was considered 
significant for all tests.
Blood raman measurements
Blood in aliquots of 0.5 mL were sampled from each rat 
group sacrificed at 24 hours. These were then dissolved in an 
equal volume of lysis buffer (1% sodium dodecyl sulfate, 1% 
Triton X-100, 40 mM Tris acetate, 10 mM ethylenediamine 
tetra-acetic acid, and 10 mM DTT) for detection of SWCNT 
in the blood samples by Raman spectroscopy.
Surface-enhanced Raman spectroscopy was also used 
to enhance SWCNT Raman scattering.22,23 Volumes as low 
as 10 µL of homogenized blood were put on a gold-coated 
silicon surface (Mesophotonics United, Southampton, UK) 
to enhance the Raman signal, and the spectra were acquired 
using the same parameters as described above.
histopathology
For each rat in each group, a portion of the lung, liver, spleen, 
and one kidney were removed for histological analysis. 
The organs were fixed in formaldehyde, dehydrated, and 
embedded in paraffin. Transverse sections 5 µm in thickness 
were cut (Leica 2045 microtome) and stained with hema-
toxylin and eosin. This is a routine staining method which 
provides excellent contrast between elastic fibers, cytoplasm, 
and connective tissues, and allows assessment of the integrity 
of the tissue, and additionally localizing SWCNT aggregates 
without any specific coloration.
Iron dosage in rat organs
Portions of lung, liver, spleen, and one kidney from the raw 
SWCNT and Sinerem groups of rats were also removed for 
iron assay using ICP-OES for comparison with noninvasive 
MRI measurements. Samples were dried at 80°C, weighed, 
and then mineralized in 5 mL nitric acid and 2 mL   hydrogen 
peroxide in a microwave oven (same conditions). Iron 
detection was carried out after dilution of the samples as 
described above.
hr-MAs NMr spectroscopy
The liver tissue samples were analyzed by 1H MAS NMR 
spectroscopy using a 9.4 T (proton frequency 400.13 mHz) 
Bruker DRX Avance spectrometer (Bruker Biospin, 
  Rheinstetten, Germany) equipped with a 4 mm 1H-13C-31P 
HR-MAS probe head. Approximately 15 mg of frozen 
liver tissue (duplicate) sampled using a 3 mm biopsy 
punch was introduced in a 4 mm zirconium oxide rotor and 
adjusted to 50 µL with 1 mM trimethylsilylpropionate in 
D2O solution. The rotor was then sealed and transferred 
into the precooled probe. Samples were spun at 4 kHz, 
and temperature was maintained at 4°C to prevent tissue 
degradation. One-dimensional spectra were all acquired 
using a Carr-Purcell-Meiboom-Gill pulse sequence to 
attenuate macromolecule and lipid resonances, synchro-
nized with the spinning rate (interpulse delay 250 µsec, 
total spin echo time 30 msec). Residual water signal was 
presaturated during the two second relaxation delay time. 
Total acquisition of one spectrum with 256 scans lasted 
16 minutes. Resonance assignment was performed as pre-
viously described by Waters et al.24
hr-MAs data statistical analysis
Data preprocessing
A 0.5 Hz line broadening was applied to all data before 
  Fourier transform. Data were phased and aligned on the 
  trimethylsilylpropionate chemical shift (fixed to 0 ppm). 
All spectral regions between 4.65 and 0.5 ppm were then 
  segmented in 0.02 ppm rectangular buckets using Bruker 
software AMIX version 35.1 (Bruker, Wissembourg, 
France). Buckets were normalized to total intensity. The 
bucket tables (the X matrix) were then loaded in the 
SIMCA-P software version 10 (Umetrics, Umea, Sweden) 
and scaled to unit variance before partial least squares-
discriminant analysis.
Principal component and partial least  
squares-discriminant analyses
Unsupervised multivariate principal component analysis 
was carried out as a first step to determine if NMR variables 
could discriminate between the SWCNT-injected animals and 
controls. Partial least squares-discriminant analysis was then 
run by adding a supplementary data matrix Y, containing our 
experimental groups for better discrimination of populations. 
All partial least squares-discriminant models were crossvali-
dated to enable evaluation of the statistical significance of 
the model. Crossvalidation lead to calculation of the Q2Y 
and R2Y factors. Typically, a robust model has an R2 . 0.5 
and a Q2 . 0.4. All results are visualized in this paper by 
scores plots.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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rNA isolation, cDNA synthesis,  
and quantitative rT-Pcr analysis
Total RNAs from the liver were prepared using a total RNA 
isolation kit (Macherey-Nagel, Düren, Germany), includ-
ing the DNase treatment step to avoid contamination with 
genomic DNA. Complementary DNA was synthesized using 
SuperScript II Reverse Transcriptase (Invitrogen, Cergy 
Pontoise, France), from 1 µg of total RNA in a final volume 
of 100 µL. Quantitative RT-PCR for seven genes was per-
formed with the ABI PRISM 7900 sequence detection system 
and SYBR Green dye (Applied Biosystems, Forster City, 
CA) according to the manufacturer’s protocol. Primers were 
designed using Primer Express program (see Table 1). mRNA 
levels were normalized against reference gene RPLP0 mRNA 
(the large P0 subunit of the acidic ribosomal phosphoprotein). 
Amplification of specific transcripts was confirmed by melting 
curve profiles generated at the end of the PCR program.
The fluorescence cycle threshold (Ct) was calculated to 
quantify the relative amount of gene expression. The mRNA 
levels of genes of interest (R) were expressed relative to   levels 
of RPLP0, (∆Ct = CtR - CtRPLP0) and the relative amount of 
R mRNA levels between treated and control rats is given by 
2-∆∆Ct, where ∆∆Ct = [∆Ct(R) of treated rats group] - [mean 
of ∆Ct(R) of control rat group]. The   Student’s t-test for paired 
data was used for statistical analysis of the results obtained.
Results and discussion
Physicochemical characteristics  
of sWcNT
Following ICP-OES characterization of the prepared SWCNT 
solutions, it was found that the raw sample contained 11% 
(w/w) iron, while the purified and functionalized samples 
contained 2% and 0.7%, respectively.
In vitro Raman spectra of the SWCNT suspensions 
revealed very similar profiles, with the presence of charac-
teristic SWCNT peaks (Figure 1). Radial breathing mode 
features (appearing between 190 cm-1 and 254 cm-1) which 
correspond to the atomic vibration of the C atoms in the 
radial direction, are very useful for characterizing nanotube 
diameters.25 The tangential graphene-like G-band (appearing 
at 1582 cm−1 for raw and purified SWCNT and at 1578 cm−1 
for functionalized SWCNT) which gives information about 
the metallic character of the SWCNT in resonance,26 was used 
to detect nanotubes in solution and blood because it is rela-
tively insensitive to the diameter and bundling of nanotubes 
and present a high Raman scattering intensity.10
To investigate the magnetic properties of the differ-
ent SWCNT samples, zero-field-cooled and field-cooled 
magnetization measurements were performed using a 
SQUID magnetometer. Figure 2A shows the temperature 
dependence of zero-field-cooled and field-cooled measure-
ments under the applied magnetic field for pristine raw 
and purified SWCNT, functionalized SWCNT, and USPIO 
nanoparticles. The measurements indicate clearly that the 
magnetization of USPIO nanoparticles is much larger 
than that of raw SWCNT. Field dependence magnetization 
Table 1 List of primer sequences for gene expression analyses by quantitative real-time polymerase chain reaction
Gene Accession number Sense primer Antisense primer
rPLP0 NM_022402.1 5′-gccAAggTcgAAgcAAAgg-3′ 5′-ccgAATcccATgTccTcATc-3′
cpt1a NM_031559.2 5′-cATTAcAAggAcATgggcAAgTT-3′ 5′-cggAAgAgccgggTcAT-3′
cyp4b1 NM_016999.2 5′-TccAgTggATcgggAAAgg-3′ 5′-gcggTgcTggAAccATTTT-3′
Fstl1 NM_024369.2 5′-cggcgccggATcATc-3′ 5′-gAgAAccAgccATcTggAATg-3′
hmox1 NM_012580.2 5′-TcggTAgAggcggcTgTTc-3′ 5′-gTcAAcATggAcgccgAcTA-3′
TNFα NM_012675.3 5′-cgccAccggcAAggA-3′ 5′-gAcATTccgggATccAgTgA-3′
TgFβ1 NM_021578.2 5′-gAggTgAccTgggcAccAT-3′ 5′-ggccATgAggAgcAggAA-3′
Abbreviations: cpt1, carnitine palmitoyl-transferase 1; cyp4b1, cytochrome P450, family 4, subfamily b, polypeptide 1; Fstl1, follistatin-like 1; hmox1, heme oxygenase 1; 
TNFα, tumor necrosis factor alpha; TgFβ, transforming growth factor beta.
100 300
RBM
G-band
R-SWCNT
P-SWCNT
f-SWCNT
R
a
m
a
n
 
i
n
t
e
n
s
i
t
y
500 1500 1700
Figure 1 Normalized Raman spectra of raw, purified, and functionalized SWCNT 
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of interest, ie, the liver, spleen, and kidneys, was chosen as 
an index of SWCNT deposition.
In the USPIO-injected group, a 2–3-fold decrease of 
CNR in the spleen and liver was observed up to 7 days after 
injection and in the kidneys at the 5-hour imaging time point. 
This effect decreased gradually over the 2-week investigation 
period, but CNR values were still significantly lower than 
those of the control groups in the spleen and liver (Figure 3). 
Similarly, in the group injected with raw SWCNT, a 1–2-fold 
decrease in CNR was detected in the spleen up to 7 days, in 
the liver up to 2 days, and in the kidneys up to 5 hours after 
injection. This effect decreased with time, and CNR values 
became comparable with those in the control groups.
No statistically significant changes in CNR values were 
measured in the purified and functionalized SWCNT-injected 
groups during the 2-week investigation (Figure 3) because 
SWCNT detection using MRI relies mainly on their intrinsic 
iron impurities. The small variation in CNR may be due to 
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Figure 2 superconducting quantum interference device magnetization measurements. 
A) Temperature dependence of zero-field-cooled and field-cooled measurements, 
recorded at a magnetic field of 50 Oe for raw, purified, and functionalized SWCNT 
compared with UsPIO nanoparticles. B) Normalized field dependence magnetization 
of raw and purified SWCNT recorded at room temperature (300 K).
Abbreviations: R, raw; P, purified; f, functionalized; sWcNT, single-walled carbon 
nanotubes; UsPIO, ultrasmall supermagnetic iron oxide.
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Figure 3 Contrast-to-noise ratio variation of USPIO, raw, purified, and functionalized 
sWcNT injected groups compared with control values at 5 hours, and days 1, 2, 7, 
and 14 investigation time points in the A) spleen, B) liver, and C) kidney. 
Note: Asterisks indicate statistically different values from the control group (P , 0.05).
Abbreviations: R, raw; P, purified; f, functionalized; sWcNT, single-walled carbon 
nanotubes; UsPIO, ultrasmall supermagnetic iron oxide.
measurements were also performed to compare raw and 
purified SWCNT. When normalizing to the iron percent-
age found with ICP measurements, comparable curves 
were observed for raw and purified SWCNT (Figure 2B) 
which indicates that the purification process does not alter 
the particle size.
Due to their strong magnetic moment, iron particles 
induce magnetic field inhomogeneities in their vicinity and 
attenuate the NMR signal of water molecules in surround-
ing tissues. With these contrast properties, raw SWCNT or 
iron-labeled SWCNT can be compared with iron-based MRI 
contrast agents used in noninvasive cellular and molecular 
MRI characterization for the whole body.13
MrI protocol
To evaluate the presence of SWCNT in systemic organs, 
a gradient echo imaging sequence sensitive to changes in 
susceptibility effect was used. CNR measured in the regions International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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the presence of some paramagnetic sites on the tube wall 
due to SWCNT purification and functionalization (ie, acid 
treatment). Although weaker than iron particles in relaxing 
proton spins, these paramagnetic sites may contribute to 
MRI contrast. These findings indicate that iron impurities 
can be used for efficient detection of raw SWCNT or iron 
containing SWCNT in systemic organs using standard proton 
MRI techniques.
Controlling the iron impurity dose or specifically labeling 
SWCNT with iron nanoparticles at different iron percentages 
(internal versus external labeling) offer the possibility to 
track the different SWCNTs accurately in vivo and, therefore, 
future monitoring of novel therapeutic SWCNT in different 
inflammatory or cancerous organs will be feasible.
ex vivo analysis
After completion of the imaging studies, the same number of 
animals was sacrificed (n = 4 per group) at day 1 and day 14 
by exsanguination under isoflurane anesthesia. Spleen, liver, 
kidneys, and blood were removed for a series of ex vivo 
post-mortem blood Raman measurements, iron assay of rat 
organs, and histopathological analyses.
Raman spectroscopy measurements performed on 
homogenized blood samples to detect the presence of 
nanotubes 24 hours after SWCNT injection did not reveal 
the presence of the characteristic G-band, with a similar pro-
file as compared with controls (data not shown). To increase 
the detection sensitivity of the presence of SWCNT in 
the blood, a surface-enhanced Raman scattering technique 
was also used. Surface-enhanced Raman spectroscopy is a 
plasmonic effect whereby molecules adsorbed onto nanor-
oughened noble metal surfaces show a dramatic increase in 
the incident electromagnetic field, resulting in high Raman 
intensities.23 Figure 4 shows the spectra of the different 
blood samples and confirms the absence of SWCNT in the 
blood samples.
The absence of SWCNT in the blood 24 hours after 
injection is in accordance with reported studies showing that 
the blood circulation of SWCNT is limited to a few hours 
(16 hours maximum), and can vary with the type of nanotubes 
used and their functionalization.10,27
To obtain an estimation of the amount of injected nano-
particles recovered in different organs at the day 1 and day 
14 time points and to correlate these with MRI readouts, 
ex vivo quantification of iron by the ICP-OES technique 
was used. Due to significant basal endogen iron concentra-
tion in organs as compared with the injected dose of iron, 
an iron assay was only performed for the spleen, liver, 
kidneys, lungs, and blood for the control, USPIO, and raw 
SWCNT groups.
A statistically significant increase in iron was measured 
in the spleen and liver for both the day 1 and day 14 USPIO 
groups and for the raw SWCNT day 1 group (Figure 5), 
which is in accordance with the obtained CNR attenuation 
in the MRI images (Figure 3).
Histopathological analyses were performed at day 1 and 
day 14 after injection to compare with the MRI readouts 
and to assess the integrity of the tissue and localize the pres-
ence of SWCNT aggregates after injection. Due to van der 
Waals forces, SWCNT bundle into ropes, which are further 
associated into loose aggregates, and may be accessible for 
detection using light microscopy.
No histopathological changes or any signs of acute 
toxicological effects were observed in the different organs 
after the injection of both functionalized and well dispersed 
pristine SWCNT. At day 1 after injection, liver, spleen, 
and lung slices showed the presence of small SWCNT and 
USPIO aggregates (Figure 6). No presence of SWCNT 
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was detected 2 weeks after injection. However, the USPIO 
nanoparticles were still detectable in liver and spleen slices 
at that time point.
To monitor the general health of the animals, body 
weight was assessed throughout the experimental schedule. 
Upon SWCNT injection, and throughout the entire study, 
no unusual behavior or differences between groups were 
observed. Starting with a weight of 244 ± 8 g (n = 32), the 
treated animals had a normal weight gain, weighing 336 ± 7 g 
at the completion of the 2-week follow-up study, identical 
to controls (n = 8).
hr-MAs NMr analysis
HR-MAS  1H NMR is a well established technique for 
studying the endogenous metabolic changes caused by 
drug toxicity and disease processes.28–30 It was performed 
in this study to assess the biological impact of SWCNT 
injection on liver metabolism as a general index of toxicity. 
HR-MAS 1H NMR spectroscopy of intact tissue enables the 
simultaneous measurement of both lipids and low molecular 
weight metabolites, which is important in a toxicological 
diagnosis. This approach is capable of detecting a wide 
range of metabolites in intact tissue, circumventing the 
need for extraction procedures that may introduce artifacts 
in the quantification of some metabolites and allowing the 
investigation of metabolic compartmentalization within 
tissues.
A representative spectrum of intact control liver with the 
assigned peaks is shown in Figure 7A (bottom). The main 
peaks arise from glucose, glycogen, trimethylamine-N-oxide, 
and lipid moieties. Spinning tissue samples at high speed at 
the magic angle markedly improves spectral resolution and 
information content.
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Figure  6  hematoxylin  and  eosin-stained  histopathological  cuts  of  lung  lobe   
(A control, B injected) and liver (C control, D injected) showing the presence of 
black sWcNT aggregates after functionalized sWcNT injection at day 1 investigation 
time point.
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No variation was observed among the analyzed liver 
samples extracted from the different experimental group. 
Principal component analysis, the most commonly used 
statistical method for the discrimination of variations in 
NMR spectra, did not reveal any differences between 
the analyzed liver samples, with no clustering in the 
principal component analysis plot (Figure 7B, R2 = 0.84, 
Q2 = 0.6).
Partial least squares-discriminant analysis, a technique 
that generalizes and combines features from principal compo-
nent analysis and multiple regression, was run to discriminate 
between populations of rats by adding a supplementary data 
matrix containing our experimental groups, ie, at day 1 and 
day 14. Because the groups were relatively small (based 
upon the kind of nanotubes injected), the sole effect of age 
could be tested. Therefore, no significant variation in liver 
metabolites was observed after SWCNT injection, but the 
classification did allow the clustering of spectra according to 
age (Figure 7C, R2 = 0.52, Q2 = 0.47). Age metabolic profile 
evolution is not based on a single metabolic variation, but 
rather on a global evolution of the spectrum due to age-related 
organ maturation.31
Quantitative rT-Pcr
To confirm HR-MAS NMR readouts and validate its sen-
sitivity in detecting endogenous metabolic changes after 
nanoparticle injection, quantitative RT-PCR was performed 
on liver samples for different genes. The relative expres-
sion of six genes selected for their identified function in 
steatosis/  cirrhosis, fatty acid metabolism, oxidative stress, or 
transport in the rat liver (Fstl1, Cpt1, Hmox1, and Cyp4b1, 
respectively)32 was determined, as well as transforming 
growth factor-β and tumor necrosis factor-α, which serve as 
chemical mediators in the inflammatory response.
No statistical variation was observed between the treated 
and control rats, nor between different groups of treated rats 
with regard to Cpt1, Cyp4b1, Hmox1, and tumor necro-
sis factor-α expression 24 hours (Figure 8A) or 14 days 
(Figure 8B) after injection. Fstl1 and transforming growth 
factor-β mRNA levels were slightly increased (in the raw 
pristine SWCNT-treated rats and in raw and purified pristine 
SWCNT-treated rats, respectively) at 24 hours after injection 
compared with control rats (Figure 8A), but these two genes 
recovered expression levels similar to those of control rats 
14 days after injection (Figure 8B).
These results were found to be totally in accordance with 
the HR-MAS results, whereby no variation was observed 
among the analyzed liver samples extracted from the dif-
ferent experimental groups. Injection of SWCNT did not 
seem to trigger hepatotoxicity, while it has been shown that 
administration of carbon tetrachloride affected lipid homeo-
stasis in the liver,33 and was responsible for hepatic fibrosis 
through chemical mediators, such as transforming growth 
factor-β or tumor necrosis factor-α.33,34 More recently, Chung 
et al32 have reported that Hmox1, induced as a protective 
mechanism against oxidative stress, was highly expressed 
in rat liver 60 days after carbon tetrachloride injection, and 
Cpt1 expression with other genes responsible for fatty acid 
degradation were downregulated at 60 days. These authors 
also showed that Fstl was a fibrosis/cirrhosis-specific gene, 
and was highly upregulated at 90 days after injection of 
carbon tetrachloride.
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Conclusion
In conclusion, this study illustrates the potential of noninva-
sive MRI protocols for assessing longitudinally the biodistri-
bution of SWCNT with associated intrinsic metal impurities. 
The same approach can be used for any other magnetically 
labeled nanoparticles. A transitional accumulation of raw 
SWCNT was detected in the spleen (up to day 7), liver (up 
to day 2), and kidney (up to 5 hours). MRI readouts were 
correlated and confirmed by ex vivo Raman spectroscopy 
performed on blood samples, as well as iron assay and his-
tological analysis performed on different body organs.
No acute toxicological effect on liver metabolism was 
observed after injection of both well dispersed and function-
alized SWCNT assessed using ex vivo HR-MAS 1H NMR, 
with no clustering of NMR spectra using principal component 
analysis (specific biomarkers of toxicity) as confirmed using 
quantitative RT-PCR analysis.
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